CD19 and Parkinson disease: Results indicated no significant difference of total CD19+ B cells(%) between patients with PD and controls. A significant decrease in naïve B cells, with a significant increase in both USM B cells and DNM B cells, was observed in patients with PD compared with controls, with no difference in SM B cells.